Mandelkow E-M. and Mandelkow E. (1993). Tau as a marker for Alzheimer's disease. Trends Neurosci;18, 480-3
2.
Roses A.D. (1994). Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol. Exp Neurol; 53, 429-37
3.
Sanan D.A., Weisgraber K.H., Russell S.J., Mahley R.W., Huang D., Saunders A., Schmechel D.,
4.
Wisniewski T., Frangione B., Roses A.D. and Strittmatter W.J. (1994). Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils . J Clin Investig; 94, 860-9
5.
Saunders A.M., Strittmatter W.J., Schmechel D., GEORGE Hyslop P H S, Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crappermaclachlan D.R., Alberts M.J., Hulette C. and Crain B. (1993). Association of Apolipoprotein-E Allele epsilon-4 with Late-Onset Familial and Sporadic Alzheimers Disease. Neurology; 43, 1467-1472
6.
Schwarzman A.L., Gregori L., Vitek M.P., Lyubski S., Strittmatter W.J., Enghilde J.J., Bhasin R., Silverman J., Weisgraber K.H., Coyle P.K., Zagorski M.G., Talafous J., Eisenberg M., Saunders A.M., Roses A.D. and Goldgaber D. (1994). Transthyretin sequesters amyloid β-protein and prevents amyloid formation. Proc Natl Acad Sci; 91, 8368-8372
7.
Selkoe (1994a). Normal and abnormal biology of the β-amyloid precursor protein. Ann Rev Neurosci; 17, 489-517
8.
Selkoe D.J. (1994b) Alzheimer's disease: A central role for amyloid . J Neuropathol Exp Neurol; 53, 438-447
